Interferon β therapy for multiple sclerosis
- 1 November 1998
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 352 (9139) , 1486-1487
- https://doi.org/10.1016/s0140-6736(98)00057-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosisMultiple Sclerosis Journal, 1997
- Characterization of MRI response to treatment with interferon beta-1b: Contrast-enhancing MRI lesion frequency as a primary outcome measureNeurology, 1997
- Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosisNeurology, 1993